1.98
price down icon1.98%   -0.04
after-market Handel nachbörslich: 1.98
loading

Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.17%
23.02
22.53 26.65 31.82 30.61
Interest Income/Expense
6.13%
0.383
0.408 0.405 0.406 0.427
Depreciation and Amortization
50.00%
0.10
0.20 0.20 0.20 0.20
Operating Income/Loss
2.17%
-23.02
-22.53 -26.65 -31.82 -30.61
Income/Loss From Continuing Operations Before Tax
3.18%
-22.85
-22.14 -25.95 -30.75 -29.16
Income/Loss From Continuing Operations After Tax
3.18%
-22.85
-22.14 -25.95 -30.75 -29.16
Net Income/Loss
3.18%
-22.85
-22.14 -25.95 -30.75 -29.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.62%
0.2061
53.58 53.45 53.36 0.6304
Diluted Average Shares
99.62%
0.2061
53.58 53.45 53.36 0.6304
Basic Earnings Per Share
2.44%
-0.42
-0.41 -0.49 -0.58 -0.53
Diluted Earnings Per Share
2.44%
-0.42
-0.41 -0.49 -0.58 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):